Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:45 am
| PEG Ratio | 7.07 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mphasis Ltd, a prominent player in the IT Consulting and Software sector, reported a current share price of ₹2,829 and a market capitalization of ₹53,910 Cr. Over the past fiscal years, Mphasis has demonstrated steady revenue growth, with sales increasing from ₹11,961 Cr in March 2022 to ₹13,798 Cr in March 2023. The trailing twelve months (TTM) revenue stood at ₹14,906 Cr, indicating a robust upward trajectory. In terms of quarterly performance, the company recorded sales of ₹3,520 Cr in September 2022, which slightly declined to ₹3,276 Cr by September 2023, but rebounded to ₹3,338 Cr in December 2023. This fluctuation in quarterly sales highlights the seasonal variations typical in the IT sector, where demand can be influenced by client budget cycles and project timelines. The company has maintained an operating profit margin (OPM) of around 18% consistently, reflecting effective cost control measures and operational efficiency.
Profitability and Efficiency Metrics
Mphasis exhibited notable profitability metrics, with a net profit of ₹1,785 Cr and a return on equity (ROE) of 18.2%, underscoring the company’s effective management of shareholder funds. The operating profit margin (OPM) remained stable at 18% for most of the reported quarters, with a slight uptick to 19% projected for March 2025. The interest coverage ratio (ICR) was reported at an impressive 17.53x, showcasing the company’s ability to cover interest expenses comfortably. However, the net profit margin showed a slight decline from 12.51% in March 2021 to 11.96% in March 2025, indicating potential pressures on profitability. Mphasis also maintained a cash conversion cycle (CCC) of 73 days, which is relatively favorable compared to industry peers, suggesting efficient management of working capital and debtor collections. Overall, the company’s profitability and efficiency ratios reflect a well-managed operation, though continuous monitoring of margins is necessary to mitigate any adverse trends.
Balance Sheet Strength and Financial Ratios
The balance sheet of Mphasis demonstrates solid financial health, with total assets reported at ₹14,744 Cr as of March 2025. The company has maintained a conservative leverage profile, with borrowings standing at ₹1,979 Cr, resulting in a debt-to-equity ratio of just 0.11, which is significantly lower than the industry average. This low level of debt enhances financial stability and reduces risk in times of economic uncertainty. Additionally, Mphasis reported reserves of ₹9,432 Cr, indicating a strong buffer for future investments and operational needs. The price-to-book value (P/BV) ratio stood at 4.94x, suggesting that the market values the company favorably compared to its book value. Furthermore, the return on capital employed (ROCE) was recorded at 22.7%, indicating effective utilization of capital for generating profits. Overall, Mphasis’s balance sheet reflects a prudent financial strategy, positioning the company well for sustainable growth.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mphasis reveals a balanced distribution of ownership, with promoters holding 40.10% of the equity, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) accounted for 18.52% and 37.08%, respectively. This distribution indicates a healthy level of institutional interest, which typically signifies investor confidence in the company’s growth prospects. Over the past year, there has been a noticeable decline in promoter holding from 55.65% in December 2022 to 40.10% in September 2025, which may reflect strategic divestments or capital restructuring. Meanwhile, DIIs have increased their stake, indicating strong institutional support. The number of shareholders stood at 145,611, reflecting a broad retail base. This diversified ownership structure enhances stability and mitigates volatility, bolstering investor confidence in Mphasis’s long-term viability.
Outlook, Risks, and Final Insight
The outlook for Mphasis appears positive, driven by its strong financial performance and operational efficiencies. However, potential risks include the increasing competition in the IT services sector, which could pressure margins and market share. Additionally, fluctuations in global demand for IT services and changing regulatory environments could pose challenges. The company’s robust balance sheet and low debt levels provide a cushion against these risks, allowing for strategic investments and growth initiatives. Mphasis’s ability to navigate these challenges while capitalizing on emerging opportunities will be crucial for its sustained performance. Overall, while the company is well-positioned for growth, it must remain vigilant against market dynamics that could impact its profitability and shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 3.38 Cr. | 225 | 225/98.4 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 13.2 Cr. | 22.3 | 22.3/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 109 Cr. | 67.1 | 101/17.6 | 53.5 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 11.5 Cr. | 39.7 | 64.9/33.1 | 7.79 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 26.8 Cr. | 78.0 | 165/67.0 | 18.2 | 15.0 | 1.28 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 123,342.81 Cr | 836.47 | 47.01 | 158.22 | 0.76% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,520 | 3,506 | 3,361 | 3,252 | 3,276 | 3,338 | 3,412 | 3,422 | 3,536 | 3,561 | 3,710 | 3,732 | 3,902 |
| Expenses | 2,902 | 2,889 | 2,763 | 2,665 | 2,681 | 2,737 | 2,773 | 2,804 | 2,888 | 2,883 | 3,007 | 3,030 | 3,180 |
| Operating Profit | 618 | 618 | 599 | 587 | 596 | 601 | 639 | 619 | 648 | 678 | 703 | 703 | 722 |
| OPM % | 18% | 18% | 18% | 18% | 18% | 18% | 19% | 18% | 18% | 19% | 19% | 19% | 18% |
| Other Income | 43 | 40 | 43 | 50 | 49 | 54 | 64 | 74 | 59 | 63 | 60 | 81 | 75 |
| Interest | 26 | 24 | 24 | 24 | 34 | 53 | 50 | 50 | 40 | 39 | 36 | 42 | 44 |
| Depreciation | 80 | 82 | 83 | 87 | 89 | 103 | 131 | 105 | 104 | 132 | 135 | 132 | 128 |
| Profit before tax | 555 | 551 | 534 | 526 | 522 | 499 | 522 | 537 | 563 | 569 | 591 | 610 | 625 |
| Tax % | 25% | 25% | 24% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 24% | 28% | 25% |
| Net Profit | 418 | 412 | 405 | 396 | 392 | 374 | 393 | 405 | 423 | 428 | 446 | 442 | 469 |
| EPS in Rs | 22.24 | 21.89 | 21.51 | 21.01 | 20.78 | 19.79 | 20.81 | 21.39 | 22.37 | 22.56 | 23.49 | 23.22 | 24.65 |
Last Updated: December 29, 2025, 10:34 pm
Below is a detailed analysis of the quarterly data for Mphasis Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,902.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,732.00 Cr. (Jun 2025) to 3,902.00 Cr., marking an increase of 170.00 Cr..
- For Expenses, as of Sep 2025, the value is 3,180.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,030.00 Cr. (Jun 2025) to 3,180.00 Cr., marking an increase of 150.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 722.00 Cr.. The value appears strong and on an upward trend. It has increased from 703.00 Cr. (Jun 2025) to 722.00 Cr., marking an increase of 19.00 Cr..
- For OPM %, as of Sep 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 19.00% (Jun 2025) to 18.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 75.00 Cr.. The value appears to be declining and may need further review. It has decreased from 81.00 Cr. (Jun 2025) to 75.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 44.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.00 Cr. (Jun 2025) to 44.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 128.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 132.00 Cr. (Jun 2025) to 128.00 Cr., marking a decrease of 4.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 625.00 Cr.. The value appears strong and on an upward trend. It has increased from 610.00 Cr. (Jun 2025) to 625.00 Cr., marking an increase of 15.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Jun 2025) to 25.00%, marking a decrease of 3.00%.
- For Net Profit, as of Sep 2025, the value is 469.00 Cr.. The value appears strong and on an upward trend. It has increased from 442.00 Cr. (Jun 2025) to 469.00 Cr., marking an increase of 27.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 24.65. The value appears strong and on an upward trend. It has increased from 23.22 (Jun 2025) to 24.65, marking an increase of 1.43.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:57 am
| Metric | Mar 2014n n 5m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,594 | 5,795 | 6,081 | 6,076 | 6,546 | 7,731 | 8,844 | 9,722 | 11,961 | 13,798 | 13,279 | 14,230 | 14,906 |
| Expenses | 2,154 | 4,925 | 5,218 | 5,108 | 5,483 | 6,407 | 7,193 | 7,919 | 9,844 | 11,365 | 10,857 | 11,583 | 12,101 |
| Operating Profit | 440 | 870 | 863 | 969 | 1,062 | 1,324 | 1,650 | 1,803 | 2,118 | 2,434 | 2,422 | 2,647 | 2,805 |
| OPM % | 17% | 15% | 14% | 16% | 16% | 17% | 19% | 19% | 18% | 18% | 18% | 19% | 19% |
| Other Income | 44 | 194 | 172 | 223 | 149 | 177 | 178 | 133 | 160 | 162 | 218 | 255 | 278 |
| Interest | 11 | 28 | 24 | 14 | 13 | 17 | 81 | 63 | 74 | 97 | 161 | 166 | 161 |
| Depreciation | 50 | 98 | 121 | 79 | 71 | 76 | 232 | 242 | 291 | 325 | 410 | 476 | 527 |
| Profit before tax | 422 | 938 | 890 | 1,099 | 1,128 | 1,407 | 1,515 | 1,631 | 1,913 | 2,173 | 2,068 | 2,260 | 2,395 |
| Tax % | 28% | 28% | 29% | 28% | 26% | 24% | 22% | 25% | 25% | 25% | 25% | 25% | |
| Net Profit | 303 | 675 | 632 | 792 | 838 | 1,073 | 1,185 | 1,217 | 1,431 | 1,638 | 1,555 | 1,702 | 1,785 |
| EPS in Rs | 14.40 | 32.10 | 30.05 | 37.62 | 43.34 | 57.64 | 63.52 | 65.06 | 76.19 | 86.94 | 82.27 | 89.55 | 93.92 |
| Dividend Payout % | 49% | 50% | 67% | 45% | 46% | 47% | 55% | 100% | 60% | 58% | 67% | 64% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -6.37% | 25.32% | 5.81% | 28.04% | 10.44% | 2.70% | 17.58% | 14.47% | -5.07% | 9.45% |
| Change in YoY Net Profit Growth (%) | 0.00% | 31.69% | -19.51% | 22.23% | -17.60% | -7.74% | 14.88% | -3.12% | -19.53% | 14.52% |
Mphasis Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | 11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 20% |
| 3 Years: | 12% |
| 1 Year: | -7% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | 19% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 11:20 am
Balance Sheet
Last Updated: December 4, 2025, 1:40 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 210 | 210 | 210 | 210 | 193 | 186 | 187 | 187 | 188 | 188 | 189 | 190 | 190 |
| Reserves | 4,905 | 5,270 | 5,645 | 5,942 | 5,289 | 5,064 | 5,643 | 6,340 | 6,755 | 7,746 | 8,606 | 9,438 | 9,432 |
| Borrowings | 540 | 575 | 461 | 260 | 390 | 543 | 571 | 513 | 527 | 198 | 1,544 | 1,116 | 1,979 |
| Other Liabilities | 1,320 | 1,312 | 1,092 | 889 | 1,109 | 1,576 | 2,339 | 2,324 | 3,214 | 3,373 | 3,662 | 4,000 | 4,672 |
| Total Liabilities | 6,974 | 7,367 | 7,408 | 7,301 | 6,980 | 7,368 | 8,740 | 9,365 | 10,684 | 11,506 | 14,000 | 14,744 | 16,273 |
| Fixed Assets | 2,404 | 2,334 | 1,597 | 1,921 | 1,884 | 2,170 | 3,013 | 3,020 | 3,774 | 4,060 | 5,533 | 5,781 | 6,091 |
| CWIP | 6 | 20 | 56 | 1 | 2 | 3 | 17 | 3 | 11 | 32 | 61 | 0 | 1 |
| Investments | 1,815 | 1,443 | 2,122 | 2,396 | 1,782 | 1,329 | 1,326 | 1,846 | 1,813 | 1,753 | 3,090 | 2,208 | 1,464 |
| Other Assets | 2,748 | 3,569 | 3,633 | 2,983 | 3,312 | 3,866 | 4,384 | 4,496 | 5,087 | 5,662 | 5,316 | 6,754 | 8,718 |
| Total Assets | 6,974 | 7,367 | 7,408 | 7,301 | 6,980 | 7,368 | 8,740 | 9,365 | 10,684 | 11,506 | 14,000 | 14,744 | 16,273 |
Below is a detailed analysis of the balance sheet data for Mphasis Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 190.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 190.00 Cr..
- For Reserves, as of Sep 2025, the value is 9,432.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,438.00 Cr. (Mar 2025) to 9,432.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,979.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,116.00 Cr. (Mar 2025) to 1,979.00 Cr., marking an increase of 863.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4,672.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,000.00 Cr. (Mar 2025) to 4,672.00 Cr., marking an increase of 672.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 16,273.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,744.00 Cr. (Mar 2025) to 16,273.00 Cr., marking an increase of 1,529.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6,091.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,781.00 Cr. (Mar 2025) to 6,091.00 Cr., marking an increase of 310.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 1,464.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,208.00 Cr. (Mar 2025) to 1,464.00 Cr., marking a decrease of 744.00 Cr..
- For Other Assets, as of Sep 2025, the value is 8,718.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,754.00 Cr. (Mar 2025) to 8,718.00 Cr., marking an increase of 1,964.00 Cr..
- For Total Assets, as of Sep 2025, the value is 16,273.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,744.00 Cr. (Mar 2025) to 16,273.00 Cr., marking an increase of 1,529.00 Cr..
Notably, the Reserves (9,432.00 Cr.) exceed the Borrowings (1,979.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014n n 5m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 440.00 | 295.00 | 402.00 | 709.00 | -389.00 | -542.00 | -570.00 | -512.00 | -525.00 | -196.00 | 1.00 | 1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109 | 39 | 39 | 38 | 45 | 45 | 34 | 35 | 68 | 67 | 67 | 73 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 109 | 39 | 39 | 38 | 45 | 45 | 34 | 35 | 68 | 67 | 67 | 73 |
| Working Capital Days | 22 | -5 | 20 | 29 | 21 | 19 | 6 | 15 | 13 | 19 | -27 | -22 |
| ROCE % | 16% | 15% | 18% | 19% | 24% | 26% | 25% | 27% | 29% | 24% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Midcap Fund | 7,771,095 | 3.61 | 2184.77 | 6,593,880 | 2025-12-15 04:18:40 | 17.85% |
| HDFC Mid Cap Fund | 4,433,657 | 1.35 | 1246.48 | 4,182,210 | 2025-12-15 04:18:40 | 6.01% |
| ICICI Prudential Technology Fund | 2,336,725 | 4.22 | 656.95 | 2,264,203 | 2025-12-15 04:18:40 | 3.2% |
| Kotak Large & Midcap Fund | 2,200,000 | 2.06 | 618.51 | N/A | N/A | N/A |
| Kotak Multicap Fund | 1,652,887 | 2.09 | 464.69 | 1,702,887 | 2025-12-15 04:18:40 | -2.94% |
| ICICI Prudential Focused Equity Fund | 1,553,625 | 3.09 | 436.79 | N/A | N/A | N/A |
| HDFC Large and Mid Cap Fund | 1,537,999 | 1.5 | 432.39 | N/A | N/A | N/A |
| HDFC Balanced Advantage Fund | 1,257,231 | 0.33 | 353.46 | N/A | N/A | N/A |
| DSP Mid Cap Fund | 1,246,962 | 1.77 | 350.57 | N/A | N/A | N/A |
| Kotak Balanced Advantage Fund | 1,155,896 | 1.81 | 324.97 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 89.87 | 82.42 | 87.05 | 76.38 | 65.18 |
| Diluted EPS (Rs.) | 89.36 | 81.83 | 86.37 | 75.61 | 64.43 |
| Cash EPS (Rs.) | 114.61 | 103.98 | 104.20 | 91.66 | 77.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 506.53 | 465.31 | 421.15 | 369.66 | 348.93 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 506.53 | 465.31 | 421.15 | 369.66 | 348.93 |
| Revenue From Operations / Share (Rs.) | 748.62 | 702.55 | 732.38 | 636.84 | 519.77 |
| PBDIT / Share (Rs.) | 152.67 | 139.66 | 137.76 | 121.29 | 103.49 |
| PBIT / Share (Rs.) | 127.61 | 117.94 | 120.50 | 105.81 | 90.56 |
| PBT / Share (Rs.) | 118.90 | 109.43 | 115.34 | 101.84 | 87.17 |
| Net Profit / Share (Rs.) | 89.55 | 82.26 | 86.94 | 76.18 | 65.05 |
| NP After MI And SOA / Share (Rs.) | 89.55 | 82.26 | 86.94 | 76.18 | 65.05 |
| PBDIT Margin (%) | 20.39 | 19.87 | 18.81 | 19.04 | 19.91 |
| PBIT Margin (%) | 17.04 | 16.78 | 16.45 | 16.61 | 17.42 |
| PBT Margin (%) | 15.88 | 15.57 | 15.74 | 15.99 | 16.77 |
| Net Profit Margin (%) | 11.96 | 11.70 | 11.87 | 11.96 | 12.51 |
| NP After MI And SOA Margin (%) | 11.96 | 11.70 | 11.87 | 11.96 | 12.51 |
| Return on Networth / Equity (%) | 17.67 | 17.67 | 20.64 | 20.60 | 18.64 |
| Return on Capital Employeed (%) | 23.19 | 22.45 | 25.76 | 25.32 | 23.34 |
| Return On Assets (%) | 11.41 | 11.00 | 14.10 | 13.30 | 12.94 |
| Total Debt / Equity (X) | 0.11 | 0.17 | 0.02 | 0.07 | 0.07 |
| Asset Turnover Ratio (%) | 0.98 | 1.03 | 1.05 | 0.90 | 0.75 |
| Current Ratio (X) | 1.57 | 1.58 | 2.13 | 1.96 | 2.40 |
| Quick Ratio (X) | 1.57 | 1.58 | 2.13 | 1.96 | 2.40 |
| Dividend Payout Ratio (NP) (%) | 61.10 | 60.64 | 52.82 | 85.08 | 53.66 |
| Dividend Payout Ratio (CP) (%) | 47.74 | 47.97 | 44.07 | 70.71 | 44.76 |
| Earning Retention Ratio (%) | 38.90 | 39.36 | 47.18 | 14.92 | 46.34 |
| Cash Earning Retention Ratio (%) | 52.26 | 52.03 | 55.93 | 29.29 | 55.24 |
| Interest Coverage Ratio (X) | 17.53 | 16.41 | 26.69 | 30.62 | 30.53 |
| Interest Coverage Ratio (Post Tax) (X) | 11.28 | 10.67 | 17.84 | 20.23 | 20.19 |
| Enterprise Value (Cr.) | 47038.62 | 45867.38 | 32991.41 | 62998.79 | 32810.46 |
| EV / Net Operating Revenue (X) | 3.31 | 3.45 | 2.39 | 5.27 | 3.37 |
| EV / EBITDA (X) | 16.21 | 17.38 | 12.71 | 27.65 | 16.95 |
| MarketCap / Net Operating Revenue (X) | 3.34 | 3.40 | 2.45 | 5.30 | 3.43 |
| Retention Ratios (%) | 38.89 | 39.35 | 47.17 | 14.91 | 46.33 |
| Price / BV (X) | 4.94 | 5.13 | 4.27 | 9.13 | 5.11 |
| Price / Net Operating Revenue (X) | 3.34 | 3.40 | 2.45 | 5.30 | 3.43 |
| EarningsYield | 0.03 | 0.03 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Mphasis Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 89.87. This value is within the healthy range. It has increased from 82.42 (Mar 24) to 89.87, marking an increase of 7.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 89.36. This value is within the healthy range. It has increased from 81.83 (Mar 24) to 89.36, marking an increase of 7.53.
- For Cash EPS (Rs.), as of Mar 25, the value is 114.61. This value is within the healthy range. It has increased from 103.98 (Mar 24) to 114.61, marking an increase of 10.63.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 506.53. It has increased from 465.31 (Mar 24) to 506.53, marking an increase of 41.22.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 506.53. It has increased from 465.31 (Mar 24) to 506.53, marking an increase of 41.22.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 748.62. It has increased from 702.55 (Mar 24) to 748.62, marking an increase of 46.07.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 152.67. This value is within the healthy range. It has increased from 139.66 (Mar 24) to 152.67, marking an increase of 13.01.
- For PBIT / Share (Rs.), as of Mar 25, the value is 127.61. This value is within the healthy range. It has increased from 117.94 (Mar 24) to 127.61, marking an increase of 9.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 118.90. This value is within the healthy range. It has increased from 109.43 (Mar 24) to 118.90, marking an increase of 9.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 89.55. This value is within the healthy range. It has increased from 82.26 (Mar 24) to 89.55, marking an increase of 7.29.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 89.55. This value is within the healthy range. It has increased from 82.26 (Mar 24) to 89.55, marking an increase of 7.29.
- For PBDIT Margin (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has increased from 19.87 (Mar 24) to 20.39, marking an increase of 0.52.
- For PBIT Margin (%), as of Mar 25, the value is 17.04. This value is within the healthy range. It has increased from 16.78 (Mar 24) to 17.04, marking an increase of 0.26.
- For PBT Margin (%), as of Mar 25, the value is 15.88. This value is within the healthy range. It has increased from 15.57 (Mar 24) to 15.88, marking an increase of 0.31.
- For Net Profit Margin (%), as of Mar 25, the value is 11.96. This value exceeds the healthy maximum of 10. It has increased from 11.70 (Mar 24) to 11.96, marking an increase of 0.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.96. This value is within the healthy range. It has increased from 11.70 (Mar 24) to 11.96, marking an increase of 0.26.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.67. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 17.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.19. This value is within the healthy range. It has increased from 22.45 (Mar 24) to 23.19, marking an increase of 0.74.
- For Return On Assets (%), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 11.00 (Mar 24) to 11.41, marking an increase of 0.41.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.03 (Mar 24) to 0.98, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.57, marking a decrease of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.57, marking a decrease of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 61.10. This value exceeds the healthy maximum of 50. It has increased from 60.64 (Mar 24) to 61.10, marking an increase of 0.46.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 47.74. This value is within the healthy range. It has decreased from 47.97 (Mar 24) to 47.74, marking a decrease of 0.23.
- For Earning Retention Ratio (%), as of Mar 25, the value is 38.90. This value is below the healthy minimum of 40. It has decreased from 39.36 (Mar 24) to 38.90, marking a decrease of 0.46.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 52.26. This value is within the healthy range. It has increased from 52.03 (Mar 24) to 52.26, marking an increase of 0.23.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 17.53. This value is within the healthy range. It has increased from 16.41 (Mar 24) to 17.53, marking an increase of 1.12.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from 10.67 (Mar 24) to 11.28, marking an increase of 0.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 47,038.62. It has increased from 45,867.38 (Mar 24) to 47,038.62, marking an increase of 1,171.24.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.31. This value exceeds the healthy maximum of 3. It has decreased from 3.45 (Mar 24) to 3.31, marking a decrease of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 16.21. This value exceeds the healthy maximum of 15. It has decreased from 17.38 (Mar 24) to 16.21, marking a decrease of 1.17.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.40 (Mar 24) to 3.34, marking a decrease of 0.06.
- For Retention Ratios (%), as of Mar 25, the value is 38.89. This value is within the healthy range. It has decreased from 39.35 (Mar 24) to 38.89, marking a decrease of 0.46.
- For Price / BV (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has decreased from 5.13 (Mar 24) to 4.94, marking a decrease of 0.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.40 (Mar 24) to 3.34, marking a decrease of 0.06.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mphasis Ltd:
- Net Profit Margin: 11.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.19% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.67% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.28
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.2 (Industry average Stock P/E: 47.01)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.96%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Bagmane World Technology Center, Bengaluru Karnataka 560048 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Jan Kathleen Hier | Chairman |
| Mr. Nitin Rakesh | Managing Director & CEO |
| Mr. Marshall Jan Lux | Non Executive Director |
| Mr. Amit Dalmia | Non Executive Director |
| Mr. Amit Dixit | Non Executive Director |
| Mr. David Lawrence Johnson | Non Executive Director |
| Ms. Courtney Della Cava | Non Executive Director |
| Mr. Kabir Mathur | Non Executive Director |
| Mr. Pankaj Sood | Non Executive Director |
| Mr. Girish Paranjpe | Independent Director |
| Ms. Maureen Anne Erasmus | Independent Director |
| Mr. Sunil Gulati | Independent Director |
FAQ
What is the intrinsic value of Mphasis Ltd?
Mphasis Ltd's intrinsic value (as of 02 January 2026) is ₹2269.89 which is 19.76% lower the current market price of ₹2,829.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹53,901 Cr. market cap, FY2025-2026 high/low of ₹3,078/2,025, reserves of ₹9,432 Cr, and liabilities of ₹16,273 Cr.
What is the Market Cap of Mphasis Ltd?
The Market Cap of Mphasis Ltd is 53,901 Cr..
What is the current Stock Price of Mphasis Ltd as on 02 January 2026?
The current stock price of Mphasis Ltd as on 02 January 2026 is ₹2,829.
What is the High / Low of Mphasis Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mphasis Ltd stocks is ₹3,078/2,025.
What is the Stock P/E of Mphasis Ltd?
The Stock P/E of Mphasis Ltd is 30.2.
What is the Book Value of Mphasis Ltd?
The Book Value of Mphasis Ltd is 506.
What is the Dividend Yield of Mphasis Ltd?
The Dividend Yield of Mphasis Ltd is 2.02 %.
What is the ROCE of Mphasis Ltd?
The ROCE of Mphasis Ltd is 22.7 %.
What is the ROE of Mphasis Ltd?
The ROE of Mphasis Ltd is 18.2 %.
What is the Face Value of Mphasis Ltd?
The Face Value of Mphasis Ltd is 10.0.